SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $175,000 | +12.9% | 16,243 | 0.0% | 0.00% | – |
| Q1 2019 | $155,000 | -16.7% | 16,243 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $186,000 | -80.5% | 16,243 | -71.1% | 0.00% | -50.0% |
| Q3 2018 | $954,000 | +16.6% | 56,277 | -2.4% | 0.00% | 0.0% |
| Q2 2018 | $818,000 | -18.4% | 57,633 | +9.2% | 0.00% | -33.3% |
| Q1 2018 | $1,003,000 | +27.0% | 52,773 | +9.5% | 0.00% | +50.0% |
| Q4 2017 | $790,000 | -65.3% | 48,200 | -68.2% | 0.00% | -71.4% |
| Q3 2017 | $2,277,000 | -3.5% | 151,800 | -43.4% | 0.01% | 0.0% |
| Q2 2017 | $2,359,000 | +69.2% | 268,100 | 0.0% | 0.01% | +75.0% |
| Q1 2017 | $1,394,000 | +633.7% | 268,100 | +2115.7% | 0.00% | +300.0% |
| Q1 2015 | $190,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |